All Stories

  1. Assessing Immunity to Hepatitis A and Hepatitis B Among Individuals in Custody Living With HIV
  2. Correctional healthcare: An opportunity for clinical pharmacists to lead and innovate
  3. Virologic outcomes of antiretroviral therapy in patients with HIV-1 following bariatric surgery: A case series and review of the literature
  4. Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?
  5. A Systematic Review: Impact of SARS-CoV-2 Infection on Morbidity, Mortality, and Viral Suppression in Patients Living With HIV
  6. Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
  7. Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists
  8. Determining support for and barriers to pharmacist‐driven research: Results of a national survey
  9. “Tele”‐ing the story of clinical pharmacy: Providing comprehensive medication management in a virtual environment
  10. Telehealth and technological applications in patient‐centered care: Implications for pharmacy learners and clinical pharmacists
  11. Telemedicine for HIV Care: Current Status and Future Prospects
  12. Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
  13. Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
  14. Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
  15. Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
  16. Weighing in on the Role of Integrase Strand Transfer Inhibitors (INSTIs) on Weight Gain: Fact or Fiction?
  17. <p>Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data</p>
  18. Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
  19. Real-world evaluation of the safety and tolerability of abacavir/dolutegravir/lamivudine in an incarcerated population
  20. Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
  21. Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
  22. Engaging in Collaborative Research: Focus on the Pharmacy Practitioner
  23. Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients
  24. Dronabinol in the treatment of weight loss
  25. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy